Current concepts in the follow-up of patients with differentiated thyroid cancer.
Benbassat
Carlos A
CA
Endocrine Institute, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel. carlosb@netvision.net.il
Mechlis-Frish
Sara
S
Guttmann
Hadassah
H
Glaser
Benjamin
B
Krausz
Yodphat
Y
D001323:Autoantibodies / Q000097:blood; D018265:Carcinoma, Papillary, Follicular / Q000473:pathology / Q000601:surgery*; D003266:Continuity of Patient Care; D006801:Humans; D009333:Neck / Q000000981:diagnostic imaging; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000517:prevention & control; D009367:Neoplasm Staging; D012333:RNA, Messenger / Q000097:blood; D011994:Recombinant Proteins / Q000627:therapeutic use; D018570:Risk Assessment; D013954:Thyroglobulin / Q000097:blood / Q000276:immunology; D013964:Thyroid Neoplasms / Q000473:pathology / Q000601:surgery*; D013965:Thyroidectomy; D013972:Thyrotropin / Q000627:therapeutic use; D014463:Ultrasonography; D051598:Whole Body Imaging
D001323:Autoantibodies; D012333:RNA, Messenger; D011994:Recombinant Proteins; D013972:Thyrotropin; D013954:Thyroglobulin